Why gene therapy is no longer a pipe dream
By Michael White,
Pacific Standard Magazine
| 01. 18. 2018
Last year will be remembered for many things, many of them not good. But here's at least one flicker of hope: 2017 may go down as the year gene therapy finally turned a corner. In late December, the Food and Drug Administration announced its approvalof the third gene therapy since August. These three therapies—two for treating cancer and one for treating a form of congenital blindness—are the first of their kind to pass muster with the FDA. And with hundreds of clinical trials for other gene therapies underway, they won't be the last. For decades, gene therapy was a pipe dream, symbolizing the unfulfilled promises of biomedical scientists who claimed that they could not just treat but actually cure disease by fixing genes. Those promises are finally beginning to be realized.
The logic behind gene therapy is simple. Many diseases are caused by a missing or defective gene; replace the broken gene with a working copy, and you cure the disease. But putting this logic into practice hasn't been so easy. For more than a century...
Related Articles
By Ian Sample, The Guardian | 07.04.2024
Biological models of human embryos that can develop heartbeats, spinal cords and other distinctive features will be governed by a code of practice in Britain to ensure that researchers work on them responsibly.
Made from stem cells, they mimic, to...
By Kevin Davies, Genetic Engineering & Biotechnology News | 06.27.2024
Physician-scientist Matthew Porteus, MD, PhD, has been a mainstay in the genome editing field for more than two decades. He trained at Stanford University Medical School before completing his residency and hematology/oncology fellowship at Boston Children’s Hospital/Dana Farber Cancer Institute...
By Peter Aldhous, Scientific American | 07.02.2024
In June a notice posted on the website of the journal Nature set a new scientific record. It withdrew what is now the most highly cited research paper ever to be retracted.
The study, published in 2002 by Catherine Verfaillie...
By Robert F. Service, Science | 07.04.2024
Image by Ed Uthman from Flickr
Last year, the U.S. Food and Drug Administration (FDA) approved two gene therapy procedures that can treat and, in some cases essentially cure sickle cell disease, a genetic blood disorder that causes pain and...